{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T10:48:32Z","timestamp":1778410112568,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019229","name":"ViewRay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.radonc.2024.110094","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:28:51Z","timestamp":1705796931000},"page":"110094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sub-lobar resections for peripheral non-small cell lung cancer measuring\u00a0\u2264\u00a02\u00a0cm: Insights from recent clinical trials"],"prefix":"10.1016","volume":"192","author":[{"given":"Suresh","family":"Senan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Famke L.","family":"Schneiders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Moghanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110094_b0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cllc.2022.11.005","article-title":"Trends in stage I lung cancer","volume":"24","author":"Singareddy","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110094_b0010","doi-asserted-by":"crossref","unstructured":"Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial Lancet 2022 Apr 23;399:1607-1617. DOI:10.1016\/S0140-6736(21)02333-3.","DOI":"10.1016\/S0140-6736(21)02333-3"},{"key":"10.1016\/j.radonc.2024.110094_b0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMoa2212083","article-title":"Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110094_b0020","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM197812212992506","article-title":"Fallacy of the five-year survival in lung cancer","volume":"299","author":"McNeil","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110094_b0025","doi-asserted-by":"crossref","unstructured":"Vansteenkiste J, De Ruysscher D, Eberhardt WE, Lim E, Senan S, Felip E, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013 Oct;24:vi89-98.doi: 10.1093\/annonc\/mdt241.","DOI":"10.1093\/annonc\/mdt241"},{"key":"10.1016\/j.radonc.2024.110094_b0030","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jgo.2021.05.005","article-title":"Age-related treatment patterns for stage I NSCLC in three European countries","volume":"12","author":"Damhuis","year":"2021","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0035","doi-asserted-by":"crossref","first-page":"P60","DOI":"10.1016\/j.cllc.2022.09.006","article-title":"Increased utilization of stereotactic body radiotherapy is associated with decreased disparities and improved survival for early-stage NSCLC","volume":"24","author":"Ganesh","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110094_b0040","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","article-title":"Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis","volume":"13","author":"Senthi","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0045","first-page":"e181390","article-title":"Association of long-term outcomes and survival with multidisciplinary salvage treatment for local and regional recurrence after stereotactic ablative radiotherapy for early-stage lung cancer","volume":"1","author":"Brooks","year":"2018","journal-title":"J Am Med Assoc Netw Open"},{"key":"10.1016\/j.radonc.2024.110094_b0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/0284186X.2021.1874617","article-title":"Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients","volume":"60","author":"Saha","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109697","article-title":"A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy","volume":"185","author":"Tonneau","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0060","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ejcts\/ezx410","article-title":"The great debate flashes: surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer","volume":"53","author":"Weder","year":"2018","journal-title":"Eur J Cadiovasc Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0070","article-title":"Quality of life after stereotactic body radiation therapy or surgery for early-stage NSCLC: A systematic review","volume":"3","author":"Iovoli","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.radonc.2024.110094_b0075","doi-asserted-by":"crossref","unstructured":"Felip E, Rosell R, Maestre JA, Rodr\u00edguez-Paniagua JM, Mora \u0301n T, Astudillo J, et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol 2010 Jul 1;28:3138-45.doi: 10.1200\/JCO.2009.27.6204.","DOI":"10.1200\/JCO.2009.27.6204"},{"key":"10.1016\/j.radonc.2024.110094_b0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.chest.2021.11.004","article-title":"Surgical outcomes for early stage non-small cell lung cancer at facilities with stereotactic body radiation therapy programs","volume":"161","author":"Syed","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2024.110094_b0085","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2010.30.0731","article-title":"Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis","volume":"28","author":"Palma","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0090","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3390\/cancers15051431","article-title":"Real-world impact of SABR on stage I non-small-cell lung cancer outcomes at a Scottish Cancer Centre","volume":"15","author":"Stares","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2024.110094_b0095","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamaoncol.2018.6993","article-title":"Measuring the integration of stereotactic ablative radiotherapy plus surgery for early-stage non-small cell lung cancer: A phase 2 clinical trial","volume":"5","author":"Palma","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijrobp.2019.11.406","article-title":"Tumor response after neoadjuvant magnetic resonance guided single ablative dose partial breast irradiation","volume":"106","author":"Vasmel","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110094_b0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(17)30071-2","article-title":"Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial","volume":"18","author":"Glynne-Jones","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0110","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.22.01096","article-title":"Risk factors for local failure following chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical cancer: Results from the EMBRACE-I study","volume":"41","author":"Schmid","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","article-title":"Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group","volume":"60","author":"Ginsberg","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.thorsurg.2006.12.008","article-title":"Lobes, fissures, and bronchopulmonary segments","volume":"17","author":"Ugalde","year":"2007","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.radonc.2024.110094_b0125","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/JTO.0000000000000218","article-title":"A brief report on outcomes of stereotactic ablative radiotherapy for a second primary lung cancer: evidence in support of routine CT surveillance","volume":"9","author":"Griffioen","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0130","doi-asserted-by":"crossref","unstructured":"Chang JY, Lin SH, Dong W, Liao Z, Gandhi SJ, Gay CM,et al. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet 2023 Jul 18;S0140-6736:01384-3.doi: 10.1016\/S0140-6736(23)01384-3.","DOI":"10.1016\/S0140-6736(23)01384-3"},{"key":"10.1016\/j.radonc.2024.110094_b0135","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jtcvs.2020.01.107","article-title":"Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer","volume":"161","author":"Hattori","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0140","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/JTO.0b013e318219aae2","article-title":"Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade","volume":"6","author":"Sawabata","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0145","article-title":"Squamous cell carcinoma predicts worse prognosis than adenocarcinoma in stage IA lung cancer patients: A population-based propensity score matching analysis","volume":"23","author":"Hao","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0150","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41586-023-05729-x","article-title":"The evolution of non-small cell lung cancer metastases in TRACERx","volume":"616","author":"Al Bakir","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2024.110094_b0155","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: A community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0160","first-page":"e2317351","article-title":"Updating the know your chances website to include smoking status as a risk factor for mortality estimates","volume":"6","author":"Woloshin","year":"2023","journal-title":"J Am Med Assoc Netw Open"},{"key":"10.1016\/j.radonc.2024.110094_b0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jtho.2022.10.020","article-title":"Respiratory and cardiometabolic comorbidities and stages I to III NSCLC survival: A pooled analysis from the International Lung Cancer Consortium","volume":"18","author":"Garc\u00eda-Pardo","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110094_b0170","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijrobp.2018.01.064","article-title":"Stereotactic ablative radiation therapy versus surgery in early lung cancer: A meta-analysis of propensity score studies","volume":"101","author":"Chen","year":"2018","journal-title":"Int J Radiiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110094_b0175","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jtcvs.2017.09.087","article-title":"Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer","volume":"155","author":"Rusthoven","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jtcvs.2020.05.123","article-title":"Institutional factors associated with adherence to quality measures for stage I and II non-small cell lung cancer","volume":"162","author":"Khorfan","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0185","doi-asserted-by":"crossref","unstructured":"Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP,et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 2013 May;143:e93S-e120S.doi: 10.1378\/chest.12-2351.","DOI":"10.1378\/chest.12-2351"},{"key":"10.1016\/j.radonc.2024.110094_b0190","doi-asserted-by":"crossref","unstructured":"Vansteenkiste J, Crin\u00f2 L, Dooms C, Douillard JY, Faivre-Finn C, Lim E,et al. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014 Aug;25:1462-74.doi: 10.1093\/annonc\/mdu089.","DOI":"10.1093\/annonc\/mdu089"},{"key":"10.1016\/j.radonc.2024.110094_b0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cllc.2023.02.006","article-title":"Differences in VA and non-VA pulmonary nodules: All evaluations are not created equal","volume":"24","author":"New","year":"2023","journal-title":"Clin Lung CAncer"},{"key":"10.1016\/j.radonc.2024.110094_b0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lungcan.2021.09.012","article-title":"Analysis of the baseline performance of five UK lung cancer screening programmes","volume":"161","author":"Balata","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110094_b0205","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1164\/rccm.201209-1651OC","article-title":"Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial","volume":"187","author":"Horeweg","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.radonc.2024.110094_b0210","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jtcvs.2019.05.015","article-title":"Commentary: Invasive mediastinal staging for patients with lung cancer-We need to do better!","volume":"158","author":"Kozower","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0215","doi-asserted-by":"crossref","unstructured":"Kulshrestha S, Vigneswaran WT, Pawlik TM, Baker MS, Luchette FA, Raad W,et al. Assessment of Textbook Outcome After Surgery for Stage I\/II Non-small Cell Lung Cancer. Semin Thorac Cardiovasc Surg. 2022 Winter;34:1351-1359. doi: 10.1053\/j.semtcvs.2021.08.009.","DOI":"10.1053\/j.semtcvs.2021.08.009"},{"key":"10.1016\/j.radonc.2024.110094_b0220","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ejcts\/ezaa265","article-title":"Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery","volume":"59","author":"Ten Berge","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0225","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jtcvs.2018.03.113","article-title":"Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection","volume":"156","author":"Yendamuri","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0230","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.jtcvs.2019.01.136","article-title":"Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer \u22642 cm","volume":"157","author":"Stiles","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2024.110094_b0235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamaoncol.2022.0039","article-title":"Rates of guideline-concordant surgery and adjuvant chemotherapy among patients with early-stage lung cancer in the US ALCHEMIST study (Alliance A151216)","volume":"8","author":"Kehl","year":"2022","journal-title":"JAMA Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:18Z","timestamp":1759123638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402400015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"alternative-id":["S016781402400015X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110094","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sub-lobar resections for peripheral non-small cell lung cancer measuring\u00a0\u2264\u00a02\u00a0cm: Insights from recent clinical trials","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110094"}}